Healthy diet shown to have greater risk reduction for type II diabetes in … – The Raw Food World News
The Raw Food World NewsHealthy diet shown to have greater risk reduction for type II diabetes in …The Raw Food World News(TRFW News) Time and time again research clearly indicates numerous health benefits that come from consuming a healthy diet. A new Harvard research study examines how a healthy diet reduces risk for type 2 diabetes among women in all racial and …and more »
FDA Approves Empagliflozin/Linagliptin Combo (Glyxambi) for Type 2 (Diabetesincontrol)
The Boehringer Ingelheim/Eli Lilly and Company combination SGLT2 inhibitor and DPP-4 inhibitor Glyxambi has been approved by the FDA. The empagliflozin/linagliptin combo is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes when neither of the individual components are working as effective treatments. See this week's Item #2 and the Product of the Week.